Navigation Links
Modified gene targets cancer cells a thousand times more often than healthy cells
Date:12/17/2008

Researchers at the University of Rochester have designed a gene that produces a thousand times more protein in cancer cells than in healthy cells.

The findings may help address the prime challenge in anti-cancer therapy: improving treatments' ability to specifically and effectively target cancer cells. Using this new approach, scientists should be able to insert "self-destruct" codes into the modified gene, forcing cancer cells to kill themselves while healthy cells remain largely unaffected.

Though trials will be necessary to determine if the difference is enough to destroy tumors without harming healthy tissue, the initial findings, published in today's early edition of Proceedings of the National Academy of Sciences, are promising, say the authors.

Vera Gorbunova, assistant professor of biology at the University of Rochester, and her team, Andrei Seluanov, assistant professor of biology, and graduate student Christopher Hine, were investigating Rad51, a protein that is expressed at about five times higher level in cancer cells than in healthy cells, when they stumbled on something very unexpected.

"We stripped off some of the Rad51 gene and replaced it with a marker protein DNA to see why Rad51 was five times more abundant in cancer cells," says Gorbunova. "We wanted to see if there was any way we could boost that difference and create a really useful cancer-targeting tool. We couldn't believe it when we saw the cancer cells expressing the engineered Rad51 around a thousand times more."

When Gorbunova first saw the huge discrepancy, she thought one of her graduate students had fumbled the lab test. Further tests showed that the altered Rad51 was expressed in some cancer cells as much as 12,500 times as often as healthy cells, says Gorbunova. Such a large discrepancy means scientists should be able to use it to create versions of Rad51 that carry a "toxic bomb," which only the cancer cells will trigger.

Rad51 is normally involve
'/>"/>

Contact: Jonathan Sherwood
jonathan.sherwood@rochester.edu
585-273-4726
University of Rochester
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
2. Technique used in human ankle injuries modified to treat dogs knees
3. Genetically modified carrots provide more calcium
4. Penn Veterinary Medicine report new strategy to create genetically-modified animals
5. UQ research targets West Nile virus and dengue fever
6. New genes present drug targets for managing cholesterol and glucose levels
7. First comprehensive genomic study of common cold reveals new treatment targets
8. US Air Force grant targets medical evacuation procedures
9. Viral magic bullet targets cancer cells with help of new compound
10. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
11. N.Y. research team discovers how antidepressants and cocaine interact with brain cell targets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hills, M...LEID) will be installing its locker system and pat...ACS) at the U.S. Department of Health and Human Se...in Bethesda, MD. The locker system will support t...or protecting our nation,s medical research agency...
(Date:11/5/2009)...ent State University has been awarded a training g...cience Foundation under its Integrative Graduation...This is the first IGERT grant to be awarded to Ken...ican Recovery and Reinvestment Act of 2009, runs t...that focuses on environment aquatic resource sensi...
(Date:11/4/2009)...t. Louis, MO, November 4, 2009 Childhood obesity ...ons. With more than one fourth of advertising on d...and beverages and continuing questions about the r...vember/December issue of the Journal of Nutrition...sing aimed at children might be a large contributo...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Whooping Cough Immunity Lasts 30 Years or More 60406 1Whooping Cough Immunity Lasts 30 Years or More 60406 2Imagewrks Marketing Named Among Top 50 Fastest Growing Private Companies in Minnesota 60402 1Imagewrks Marketing Named Among Top 50 Fastest Growing Private Companies in Minnesota 60402 2Survey of State Health Departments Underscores Gaps in Foodborne Illness Response 60398 1Survey of State Health Departments Underscores Gaps in Foodborne Illness Response 60398 2Survey of State Health Departments Underscores Gaps in Foodborne Illness Response 60398 3
...hange causes temperatures to increase in Hawaii,s ...kely also creep up the mountains, invading most of...a group of endangered and remarkable birds. , A ...w discusses the likelihood of a forthcoming "disea...range of avian malaria and pox, honeycreeper distr...
... Stem cells that respond after a severe injury in...ding cells that lead to lung cancer, according to ...There are chemically resistant, local-tissue stem ...injury," said Barry R. Stripp, Ph.D., professor of...cal Center. "Cigarette smoke contains a host of to...
...ier is wounded during combat, surgeons must focus ...one and tissues. Technologies that could improve t...eloped in research laboratories across the country... military trauma centers. , Organizers of the rec... Bioengineering for Soldier Survivability want to ...
Other Biology News:Jeepers creepers: Climate change threatens endangered honeycreepers 2Jeepers creepers: Climate change threatens endangered honeycreepers 3Activated stem cells in damaged lungs could be first step toward cancer 2New center at Georgia Tech aims to improve recovery of soldiers with severe injuries 2New center at Georgia Tech aims to improve recovery of soldiers with severe injuries 3
(Date:11/9/2009)... , Product release is a r...ch subjects, research facilities and research safe...ation. , Cedar Knolls, NJ...s announced today that it has unveiled Pristima&tr...n for research facilities that track the use and c...
(Date:11/6/2009)... , TORONTO, Nov. 6 /PRNewswire-FirstCall/ - M...today that it has re-filed the Form 52-109F1 Certi...Chief Executive Officer and James Long, the Chief ...ated January 12, 2009 in connection with the annua...September 30, 2008. ,, The Company initially fi...
(Date:11/6/2009)... , SAN MATEO, Calif., Nov. 6 /PRNewswire-Firs..., Completed transfer of Qutenza(TM) E.U. Market... Made significant progress in commercial readiness...P Sales; Senior Director, Marketing; and Director,...win to board as director and Audit Committee chair...
(Date:11/5/2009)... , , TRANSPORTATION -- Gone hybrid . . . , F...tomobiles are now posted at the www.fueleconomy.g...developed and maintains for the U.S. Department of...cy. Nine of the top 10 vehicles on the best fuel e...a Prius (51 MPG city; 48 highway). "This list prov...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...ISCO, Dec. 9 Medivation, Inc.,(Nasdaq: MDVN ) p... that,Dimebon, its lead product candidate in devel...ses, potentially operates via a novel mitochondria...ebon was shown to impact two,key aspects of brain ...t,preserved mitochondrial function after brain cel...
... Conn., Dec. 9 Soliris(R) (eculizumab),a terminal...euticals, Inc.,(Nasdaq: ALXN ), was observed by ...with undiagnosed blood clots and inflammation in p...hat Soliris was observed to reduce indicators of,p...h paroxysmal nocturnal,hemoglobinuria (PNH), accor...
... Oberon FMR, Inc. was selected as...e recent BioWest 2008 Venture Showcase Competition...vert wastewater from food and beverage companies i... given top honors out of 22 total entries by a pan...m the sponsoring Colorado law firm of Dorsey &...
Other Biology Technology:Medivation Presents New Data on Dimebon's Novel Mechanism of Action 2Medivation Presents New Data on Dimebon's Novel Mechanism of Action 3Medivation Presents New Data on Dimebon's Novel Mechanism of Action 4Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 2Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 3Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 4Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 5Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 6Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 7Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 8Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 2Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 3Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 4Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 5
Rabbit Anti-Shigella Polyclonal Antibody, Unconjugated from GeneTex
...UL-3 is a member of the family of human cullin gen...o the S. cerevisiae cdc53 gene. Cullin-3 is propos...t forms a tight complex with cyclin E and targets ...ion by protesomes. Cyclin E is an activator of cdk...
...lue LED produces output at 470 nm; includes interf...r installed into rack or desktop boxes The LS-45...uces either pulsed or continuous output at 470 nm ...s. The source is designed for use with Ocean Optic...
Freund's Complete Adjuvant, Modified, Mycobacterium butyricum from Calbiochem
Biology Products: